Company / Current Liabilities per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.24
FY2025
5-year range
$0.23 / $1.17
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
#155 of 158
Health Care
What the data says
Among 158 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the top 2% for current liabilities per share. Current Liabilities per Share returned to growth in FY2025 after 2 years of decline, reaching $0.24.
Based on SEC 10-K filings.
0.24 in FY2025 with a 5-year CAGR of +2.0%.
Improved from $0.37 to $0.24 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -40.8%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 158This company $0.24 Sector average $29.75
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 5.6% year-over-year.
- Ranks #155 out of 158 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2022.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.24 | +5.6% |
| FY2024 | $0.23 | -38.6% |
| FY2023 | $0.37 | -68.1% |
| FY2022 | $1.17 | +233.8% |
| FY2021 | $0.35 | +59.6% |
| FY2020 | $0.22 | -31.7% |
| FY2019 | $0.32 | +39.4% |
| FY2018 | $0.23 | -25.2% |
| FY2017 | $0.31 | -26.8% |
| FY2016 | $0.42 | -18.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026